Programme

Overview: In this session we will showcase radiation oncology professionals and a patient representative from various parts of the world who have been strong advocates in raising awareness of radiotherapy as a poorly understood, yet vital, cancer treatment. The lack of awareness and misconceptions about radiotherapy lead to chronic lack of funding in most parts of the world, resulting in many people with cancer missing out on the treatment they need. Panel members will discuss the challenges in public and patient perceptions of radiotherapy, the dire consequences of this poor image and awareness problem, as well as ways we, as radiation oncology professionals in partnership with patients, can turn the situation around.

Overview: This symposium explores how innovation is reshaping radiotherapy across the entire clinical pathway. It begins with multimodality imaging, highlighting the practical integration of MRI and other advanced imaging techniques to enhance precision in treatment planning. The focus then shifts to the evolving role of RTTs, examining how AI and automation are transforming clinical tasks into more evaluative and decision-driven responsibilities. Finally, implementation of simulator-free radiotherapy demonstrates how these advances translate into streamlined, patient-centred workflows. Together, these sessions provide a cohesive perspective on how technology, workforce evolution, and workflow redesign are driving the future of radiotherapy practice.

Overview: • Concept of interventional radiotherapy (brachytherapy) for liver tumours • Technical aspects of CT-guided HDR brachytherapy (“direct hit” technique) • Patient selection and indications in oligometastatic disease • Treatment workflow: planning, catheter placement, and dose delivery • Clinical outcomes and toxicity based on recent multicentre and RWE studies • Comparison with other radiotherapy modalities (SBRT) • Future perspectives of brachytherapy in liver-directed therapy

Overview: Join this session for an overview of RT in the setting of rare diseases focused on thymic malignancies. Get information on indications, dosing and techniques to be used in this underrepresented patient population.